Company intelligence / Profile preview

Almus Pharmaceuticals

Chessington, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

Almus Pharmaceuticals is a leading provider of generic medicines, recognized for its award-winning 'Safety by Design' packaging intended to reduce dispensing errors. The company operates as a commercial-stage generic pharmaceutical entity with an extensive portfolio across major therapeutic areas.

Therapeutic areas: EndocrinologyCardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterologyPsychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Almus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Almus Pharmaceuticals.

Explore the full profile